当前位置:首页 - 行情中心 - 常山药业(300255) - 财务分析 - 现金流量表

常山药业

(300255)

  

流通市值:626.05亿  总市值:626.98亿
流通股本:9.18亿   总股本:9.19亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金768,522,243.45548,877,594.72266,030,861.291,046,319,008.4
  收到的税费返还8,170,495.718,165,041.857,375,821.0935,837,247.72
  收到其他与经营活动有关的现金32,326,771.1721,452,714.7912,459,631.0527,275,067.81
  经营活动现金流入小计809,019,510.33578,495,351.36285,866,313.431,109,431,323.93
  购买商品、接受劳务支付的现金430,909,663.99239,851,756.74115,797,697.8672,853,071.66
  支付给职工以及为职工支付的现金122,148,023.5881,569,342.4535,781,479.42162,128,158.79
  支付的各项税费34,179,936.7325,288,771.256,926,658.6958,666,812.72
  支付其他与经营活动有关的现金79,431,136.1858,577,680.7424,368,174.5159,565,110.69
  经营活动现金流出小计666,668,760.48405,287,551.18182,874,010.411,053,213,153.86
  经营活动产生的现金流量净额142,350,749.85173,207,800.18102,992,303.0256,218,170.07
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额---58,000
  收到的其他与投资活动有关的现金106,503,980106,060,00030,00011,265,615.92
  投资活动现金流入小计106,503,980106,060,00030,00011,323,615.92
  购建固定资产、无形资产和其他长期资产支付的现金72,037,176.7747,570,898.2228,937,497.16239,590,962.09
  支付其他与投资活动有关的现金106,568,000106,283,000228,0005,495,162
  投资活动现金流出小计178,605,176.77153,853,898.2229,165,497.16245,086,124.09
  投资活动产生的现金流量净额-72,101,196.77-47,793,898.22-29,135,497.16-233,762,508.17
三、筹资活动产生的现金流量:
  取得借款收到的现金1,984,038,918.63965,324,418.63219,323,168.631,894,898,910
  收到其他与筹资活动有关的现金84,000,00064,000,0002,283,817.15106,298,981.93
  筹资活动现金流入小计2,068,038,918.631,029,324,418.63221,606,985.782,001,197,891.93
  偿还债务支付的现金1,954,652,648.581,062,423,078.52217,817,383.891,685,212,782.94
  分配股利、利润或偿付利息支付的现金89,652,045.4359,262,110.8329,164,860.34119,928,863.59
  支付其他与筹资活动有关的现金85,593,00055,182,0006,465,445.8314,322,845
  筹资活动现金流出小计2,129,897,694.011,176,867,189.35253,447,690.061,819,464,491.53
  筹资活动产生的现金流量净额-61,858,775.38-147,542,770.72-31,840,704.28181,733,400.4
四、汇率变动对现金及现金等价物的影响2,765,798.572,654,762.671,176,593.01839,298.48
五、现金及现金等价物净增加额11,156,576.27-19,474,106.0943,192,694.595,028,360.78
  加:期初现金及现金等价物余额235,886,780.62235,886,780.62235,970,467.3230,858,419.84
  期末现金及现金等价物余额247,043,356.89216,412,674.53279,163,161.89235,886,780.62
补充资料:
  净利润--36,220,597.35--264,031,841.21
  资产减值准备--18,787,985.13-89,387,147.3
  固定资产和投资性房地产折旧-28,894,830.57-61,014,651.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,894,830.57-61,014,651.52
  无形资产摊销-4,735,575.43-11,336,402.03
  长期待摊费用摊销-1,620,735.06-1,050,676.66
  处置固定资产、无形资产和其他长期资产的损失--17,641.19-63,301.42
  固定资产报废损失-29,659.01-711,844.68
  财务费用-48,924,439.19-102,830,310.85
  投资损失----33,263,558.02
  递延所得税-3,078,696.67--970,586.45
  其中:递延所得税资产减少-3,099,897.34--928,185.07
    递延所得税负债增加--21,200.67--42,401.38
  存货的减少-126,327,489.38-190,001,583.12
  经营性应收项目的减少--124,267,569.38--21,010,245.1
  经营性应付项目的增加-137,691,798.4--82,245,575.24
  现金的期末余额-216,412,674.53-235,886,780.62
  减:现金的期初余额-235,886,780.62-230,858,419.84
  现金及现金等价物的净增加额--19,474,106.09-5,028,360.78
公告日期2025-10-302025-08-232025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑